Pliant Therapeutics Inc (NASDAQ: PLRX) Has Been Falling -28.91% Year-To-Date. Troubles Yet To Come?
During the last session, Pliant Therapeutics Inc (NASDAQ:PLRX)’s traded shares were 0.46 million, with the beta value of the company hitting 1.06. At the end